Performance of the Baxter disposable patient-controlled analgesia infusor under hyperbaric conditions.
Hyperbaric oxygen treatment may require the concurrent administration of drugs. A study was performed to assess the suitability of the infusor device from the Baxter Patient-Controlled Analgesia system, for drug delivery during hyperbaric therapy. Thirty infusor devices were used to deliver 5% dextrose, 50% dextrose or propofol solutions under conditions 1 and 2.3 atmospheres of pressure. The increased pressure caused an increase in flow of 4.27%, 1.79% and 9.84% for 5% dextrose, propofol and 50% dextrose respectively.
Radcliffe
J J
JJ
Princess Alexandra RAF Hospital, Wroughton, Swindon, Wilts.
Spencer
I
I
D016058:Analgesia, Patient-Controlled / Q000295:instrumentation*; D004209:Disposable Equipment; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D006931:Hyperbaric Oxygenation; D011312:Pressure; D015742:Propofol / Q000008:administration & dosage; D013997:Time Factors
D005947:Glucose; D015742:Propofol